242 results
S-8
EX-99.1
LSTA
Lisata Therapeutics Inc
17 Oct 22
Registration of securities for employees
4:02pm
as an Incentive Stock Option or to bring the Stock Award into compliance with Section 409A of the Code and Department of Treasury regulations and other … applicable, the Plan and Stock Award Agreements shall be interpreted in accordance with Section 409A of the Code and Department of Treasury regulations
8-K/A
EX-99.2
hm3o1qq
4 Oct 22
Other Events
4:42pm
8-K
41f42gc8o3 73z
29 Sep 22
Other Events
4:01pm
8-K
84kibui7wyat
19 Aug 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:33pm
8-K
EX-99.3
h0sdqjpz5m 24ywdmg1n
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
hwjq4vhtqw26uf
29 Jul 22
Prospectus supplement
4:06pm
8-K
EX-99.2
se527 wwtl8obf
23 May 22
Caladrius Biosciences Provides Update on Phase 2b FREEDOM Trial of XOWNA® in Coronary Microvascular Dysfunction
4:08pm
8-K
EX-99.2
ndl5uqtu3ri3cz6vhl9
5 May 22
Caladrius Biosciences Reports First Quarter 2022 Financial Results and Provides Business Update
12:00am
8-K
EX-2.1
js9prmy7ba0e ct
27 Apr 22
Caladrius Biosciences and Cend Therapeutics Announce
7:05am
8-K
EX-99.2
mdqqgbolr
22 Mar 22
Caladrius Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
4:09pm
8-K
ccuz2n iys89
18 Feb 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:47pm